Despite a rate of 2–11% (Guarini et al., 2021; Ivanova et al., 2022; Siena et al., 2018) of HER2 positive expression in CRC, the association between HER2-positive status and the prognosis of CRC is still controversial. This evidence concerns the gene ERBB2 and colorectal carcinoma.